"Reasonable pricing" clause
Executive Summary
National Institutes of Health would be directed to reinstate the "reasonable pricing" clause in Cooperative Research & Development Agreements under an amendment sponsored by Rep. Bernie Sanders (I-Vt.) included in the House version of the HHS appropriations bill. The same amendment passed the House last year but was not included in the conference version of the bill, which directed NIH to develop a report on taxpayer-funded research. In the report, NIH repeated its concern that the "reasonable pricing" clause would discourage firms from licensing federal discoveries (1"The Pink Sheet" Aug. 27, p. 3)